PHARMA 2100 ApS: Financial statements 2016
CVR: 26382785
Source: annual report 2016, Danish Business Authority
01/07/2015 – 30/06/2016
PHARMA 2100 ApS (CVR 26382785) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -2,166 the year before. Equity in the 2016 report amounted to DKK 49,826. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 49,826
- Total Assets
- DKK 49,826
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 0 | 0 | 0 | 50 t. | - |
| 2015 | - | -2 t. | -2 t. | 50 t. | - |
| 2014 | 0 | -5 t. | -5 t. | 52 t. | - |
| 2013 | 0 | -250 | -25 t. | 57 t. | - |
| 2012 | 0 | 0 | -50 t. | 83 t. | - |
Official annual report
Find more companies like PHARMA 2100 ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout PHARMA 2100 ApS
PHARMA 2100 ApS was a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company has been dissolved on 23 October 2018. The company was registered under the industry Industriel design og produktdesign. The company has 1 employee (2009). In 2017, the company reported a gross profit of DKK -20,455 and a net result of DKK -20,455 compared with DKK 0 the year before. Equity in the 2017 report amounted to DKK 29,371.